How big is the Rosacea Market?

The Rosacea Market size is expected to reach USD 2.09 billion in 2024 and grow at a CAGR of 8.74% to reach USD 3.19 billion by 2029. Read More

What is the current Rosacea Market size?

In 2024, the Rosacea Market size is expected to reach USD 2.09 billion. Read More

Which is the fastest growing region in Rosacea Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Rosacea Market?

In 2024, the North America accounts for the largest market share in Rosacea Market. Read More

What years does this Rosacea Market cover, and what was the market size in 2023?

In 2023, the Rosacea Market size was estimated at USD 1.92 billion. The report covers the Rosacea Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Rosacea Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Rosacea Market Share

Q: Who are the key players in Rosacea Market?

Aclaris Therapeutics, Bausch Health Companies, Sol-Gel Technologies Ltd., Journey Medical Corporation (Fortress Biotech, Inc.) and Galderma are the major companies operating in the Rosacea Market. Read More

Statistics for the 2023 & 2024 Rosacea market share, created by Mordor Intelligence™ Industry Reports. Rosacea share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Rosacea Industry

The rosacea market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The rosacea market has observed growing competition among leading players, majorly across the developed markets. Some of the major market players include Bausch Health Companies Inc., Galderma, LEO Pharma A/S, Journey Medical Corporation (Fortress Biotech, Inc.), and Aclaris Therapeutics, among others.